Deutsche Apotheker- und Ärztebank

Deutsche Apotheker- und Ärztebank eG, commonly known as apoBank, is a German cooperative bank headquartered in Düsseldorf. Its business is focused on the financial needs of healthcare professionals and organizations connected with the healthcare sector. The bank primarily serves physicians, dentists, psychotherapists and pharmacists, together with their relatives, professional associations and healthcare companies. Its specialist positioning differentiates it from general retail banks by combining conventional banking services with expertise in professional practice finance, healthcare-sector businesses and the financial circumstances of medical and pharmaceutical professionals. The institution traces its origins to 1902, when 18 pharmacists founded the Kredit-Verein Deutscher Apotheker in Danzig. The original cooperative model was designed to provide credit and financial support within the pharmacy profession. The organization underwent several name and structural changes during the twentieth century. In 1938 it became Deutsche Apothekerbank e.G.m.b.H., and in 1939 it merged with the Spar- und Kreditverein Deutscher Apotheker m.b.H. Following its closure in 1945, the bank was re-established in Düsseldorf in 1948 as Westdeutsche Apothekerbank e.G.m.b.H. It later developed into a nationwide specialist institution for the liberal healthcare professions and adopted its present identity as Deutsche Apotheker- und Ärztebank. ApoBank operates as a cooperative institution rather than a publicly listed company. Its members are central to the governance model, and the bank is affiliated with the National Association of German Cooperative Banks, the Bundesverband der Deutschen Volksbanken und Raiffeisenbanken (BVR). Its organizational structure includes a board of directors, a supervisory committee and an advisory council. The bank has historically maintained an extensive German branch network to support professionals during stages such as university training, practice formation, acquisition or transfer, and retirement planning. The bank's services include current and savings accounts, lending, investment products and insurance-related solutions. Its specialist offering is particularly relevant to medical practices, pharmacies and other healthcare enterprises, where financing needs may include start-up capital, premises, equipment, practice purchases and business succession. It also provides personal financial services to members of the professions and works with professional associations and companies in the healthcare industry. ApoBank became subject to direct supervision by the European Central Bank after European Banking Supervision took effect in late 2014, reflecting its designation as a significant institution. In 2016, the cooperative reported 107,000 members, approximately 406,000 customers, 2,563 employees and 84 locations. The 2008 financial crisis caused a substantial decline in net income. After no dividend was distributed for the 2009 financial year, the cooperative paid a 4% dividend for each financial year from 2010 through 2016, according to the referenced historical account. The bank also awards the Karl-Winter Medal. Since the introduction of European banking supervision at the end of 2014, apoBank has been designated a significant institution and is directly supervised by the European Central Bank. In 2016 the cooperative reported 107,000 members, approximately 406,000 customers, 2,563 employees and 84 locations. The 2008 financial crisis caused a substantial decline in net income. According to the cited historical record, no dividend was distributed for the 2009 financial year, while a 4% dividend was paid for each financial year from 2010 to 2016. The bank also awards the Karl-Winter Medal.

Deutsche Apotheker- und Ärztebank originated in the cooperative credit movement of German pharmacists. In 1902, 18 pharmacists founded the Kredit-Verein Deutscher Apotheker in Danzig. The institution was created to provide credit and financial support within the profession, establishing the occupational focus that continues to define the bank. In 1938, the organization was renamed Deutsche Apothekerbank e.G.m.b.H. The following year it merged with the Spar- und Kreditverein Deutscher Apotheker m.b.H., consolidating cooperative banking activity for pharmacists. The bank was closed in 1945. In 1948 it was re-established in Düsseldorf as Westdeutsche Apothekerbank e.G.m.b.H. From its post-war base, it expanded its role beyond a narrowly defined pharmacists' credit institution and developed into a specialist bank serving a wider range of healthcare professionals. The modern institution, known as Deutsche Apotheker- und Ärztebank and commonly branded apoBank, serves physicians, dentists, psychotherapists and pharmacists. Its customer base also includes relatives of these professionals, healthcare-sector companies and professional associations. The bank's specialist model covers personal banking as well as financing for practices, pharmacies and other healthcare businesses. This focus allows it to address professional events such as starting a practice, acquiring an existing practice, purchasing premises and planning succession. ApoBank is organized as a cooperative and is affiliated with the Bundesverband der Deutschen Volksbanken und Raiffeisenbanken, Germany's national association of cooperative banks. Governance includes a board of directors, a supervisory committee and an advisory council. In 2016, the bank was reported to have 107,000 members, 406,000 customers, 2,563 employees and 84 locations. The institution has also been part of the European banking supervisory framework. Since the introduction of European Banking Supervision in late 2014, it has been designated a significant institution and directly supervised by the European Central Bank. The 2008 financial crisis produced a major decline in net income. No dividend was distributed for the 2009 financial year, while a 4% dividend was paid for each of the financial years 2010 through 2016, as recorded in the referenced historical material. The bank awards the Karl-Winter Medal and remains an active German specialist cooperative bank for the healthcare professions.

• 2016

  Reported nationwide cooperative scale

  [1]Deutsche Apotheker- und Ärztebanken.wikipedia.org

  The bank was reported to have 107,000 members, 406,000 customers, 2,563 employees and 84 locations.

• 2014

  Became a significant institution under European banking supervision

  [1]Deutsche Apotheker- und Ärztebanken.wikipedia.org

  Following the introduction of European Banking Supervision, apoBank became directly supervised by the European Central Bank.

• 1948

  Re-established in Düsseldorf

  [1]Deutsche Apotheker- und Ärztebanken.wikipedia.org

  The bank was re-established as Westdeutsche Apothekerbank e.G.m.b.H. in Düsseldorf.

• 1945

  Bank closed after the Second World War

  [1]Deutsche Apotheker- und Ärztebanken.wikipedia.org

  The institution was closed in the post-war period.

• 1939

  Merger with a pharmacists' savings and credit association

  [1]Deutsche Apotheker- und Ärztebanken.wikipedia.org

  Deutsche Apothekerbank merged with the Spar- und Kreditverein Deutscher Apotheker m.b.H.

• 1938

  Renamed Deutsche Apothekerbank

  [1]Deutsche Apotheker- und Ärztebanken.wikipedia.org

  The institution adopted the name Deutsche Apothekerbank e.G.m.b.H.

• 1902

  Kredit-Verein Deutscher Apotheker founded

  [1]Deutsche Apotheker- und Ärztebanken.wikipedia.org

  Eighteen pharmacists founded the original cooperative credit institution in Danzig.

Specialist cooperative bank for Germany's healthcare professions and healthcare industry

• Retail banking

  Personal banking

  ApoBank provides everyday banking and savings services for members of the healthcare professions and their households. The specialist customer base includes physicians, dentists, psychotherapists and pharmacists. The product area forms the personal-banking foundation of the cooperative and is complemented by lending, investment and insurance-related services.

• Professional lending

  Practice and pharmacy financing

  The bank finances professional healthcare businesses, including medical practices and pharmacies. Relevant needs can arise when a professional establishes a practice, acquires an existing operation, invests in equipment or premises, or prepares a business succession. The offering reflects apoBank's role as a sector-focused lender rather than a general-purpose commercial bank.

• Investment services

  Investment and wealth services

  Investment products are part of the bank's broader financial-services portfolio for healthcare professionals. They support personal asset management and longer-term financial planning, alongside deposit accounts, lending and insurance-related solutions. Specific funds, mandates or product names are not identified in the supplied reference material.

• Corporate banking

  Healthcare-sector business banking

  ApoBank serves companies operating in healthcare as well as professional associations. This business scope extends the bank's cooperative specialization beyond individual practitioners and supports organizations connected with medical and pharmaceutical services. The supplied material does not specify individual corporate products or sector subsegments.

• 2014

  Participation in direct European Central Bank supervisionStrategy

  Background

  The introduction of European Banking Supervision created a common supervisory framework for significant euro-area banking institutions.

  Action taken

  ApoBank was designated a significant institution and became directly supervised by the European Central Bank.

  Aftermath

  The bank's regulatory oversight shifted into the direct supervisory framework of the ECB.

  Source

• 2009

  No dividend distributed for the 2009 financial yearOther

  Background

  The global financial crisis caused a substantial decline in the bank's net income.

  Action taken

  The cooperative did not distribute a dividend for the 2009 financial year.

  Aftermath

  The historical account states that a 4% dividend was paid for each financial year from 2010 through 2016.

  Dividend rate. 4% (Financial years 2010-2016)

  Source

• Unconfirmed

  HCL and apoBank agree to acquire gbs[2]HCL与apoBank达成收购gbs协议economictimes.indiatimes.com

  Reported: 2021-12-08

  HCL and apoBank signed an agreement with Atruvia to acquire IT consulting company Gesellschaft für Banksysteme GmbH (gbs). The transaction was expected to close in January 2022, with HCL to own 51% and apoBank 49% after closing.

1. 1Deutsche Apotheker- und Ärztebanken.wikipedia.org
2. 2HCL与apoBank达成收购gbs协议economictimes.indiatimes.com